Back

Effectiveness of RSV vaccine against cardio-respiratory hospitalizations in heart failure: a prespecified analysis of the DAN-RSV trial

30 August 2026 (09:05 - 09:15)
Organised by: Logo
Congress Presentation Part of: Approaching heart failure therapy from all angles Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kristoffer Grundtvig Skaarup

Herlev and Gentofte Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Vutrisiran is associated with preservation of intrinsic capacity and healthy ageing in patients with transthyretin amyloidosis with cardiomyopathy: post hoc analysis of HELIOS-B
Professor O. Lairez (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Machine learning approaches for the prediction of 1-year mortality after heart transplantation: a systematic review and meta-analysis
Doctor D. Mutahar (Gold Coast, AU)
Abstract Slides Video
Presentation thumbnail
Empagliflozin attenuates adverse outcomes of acute ischemic heart failure by targeting NLRP3/IL1β mediated macrophage polarization and inflammatory response
Mr G. Zhou (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Cardiac rehabilitation referral in heart failure units: clinical profile and outcomes from the Spanish National SEC-EXCELENTE-IC Registry
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and one-year survival in heart transplant recipients from donors after circulatory death versus brain death: a meta-analysis of current evidence
Assistant Professor D. Garcia Maldonado (Ciudad de Mexico, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Approaching heart failure therapy from all angles
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 09:05 CET
You may be interested in
thumbnail
Congress Presentation
Effectiveness of bivalent RSV prefusion F protein-based vaccine in individuals with and without atrial fibrillation: a prespecified analysis of the DAN-RSV trial
28 August 2026
thumbnail
Congress Presentation
Vaccine-preventable diseases in hospitalized patients with heart failure: a nationwide cohort analysis.
28 August 2020
thumbnail
Congress Presentation
Rationale and design of the ESC EURObservational research programme heart failure III registry: implementation and discovery
21 May 2023
thumbnail
Congress Presentation
Results from the largest ever individually randomised influenza vaccine effectiveness study
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources